Tear free test of Piramals Multiple Baby care products.

Not Applicable

Registration Number: CTRI/2023/11/059515

Lead Sponsor: Piramal Pharma Limited

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1.Healthy males or females, 18 to 60 years with no medical conditions of the eyes as determined by the subjects medical history and confirmed by an ophthalmologist

2. Subjects not under any doctor care for ocular or peri orbital diseases

3. The subject will refrain from using contact lenses, any topical facial products, any eye drops, false eyelashes, make up, over the counter products, or cosmetics on their eyes, eyelids, eyelashes, or the periorbital areas of the face during the study.

Exclusion Criteria

1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.

2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.

3.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.

4.Have participated in any interventional clinical trial in the previous 30 days.

5.Have a known sensitivity to any of the constituents of the test product including sensitivities to cocoamidopropyl betaine, coumarin, Aloe barbadensis etc.

6.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.

7.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
•Change in lacrimation <br/ ><br>•Change in conjunctival inflammation. <br/ ><br>•Change in cornea and iris inflammation . <br/ ><br>Timepoint: [Time frame 0-1 days] <br/ ><br>[Time frame 0-1 days] <br/ ><br>[Time frame 0-1 days] <br/ ><br>

Secondary Outcome Measures